| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunocytochemistry; human; 1:100; loading ...; fig s71e
- western blot; human; 1:1000; loading ...; fig 2g
| Fearnley G, Young K, Edgar J, Antrobus R, Hay I, Liang W, et al. The homophilic receptor PTPRK selectively dephosphorylates multiple junctional regulators to promote cell-cell adhesion. elife. 2019;8: pubmed publisher |
- immunocytochemistry; human; 1:100; fig 5a
- western blot; human; 1:1000; fig 5b
| Wu Y, Jhao Y, Cheng Y, Chen Y. 15-Deoxy-?12,14-prostaglandin J2 inhibits migration of human thyroid carcinoma cells by disrupting focal adhesion complex and adherens junction. Oncol Lett. 2017;13:2569-2576 pubmed publisher |
- immunocytochemistry; dog; 1:200; loading ...; fig 3a
| Lapierre L, Manning E, Mitchell K, Caldwell C, Goldenring J. Interaction of phosphorylated Rab11-FIP2 with Eps15 regulates apical junction composition. Mol Biol Cell. 2017;28:1088-1100 pubmed publisher |
- western blot; human; loading ...; fig 5a
| LAW M, Ferreira R, Davis B, Higgins P, Kim J, Castellano R, et al. CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment. Breast Cancer Res. 2016;18:80 pubmed publisher |
- immunocytochemistry; human; 1:100; fig 5
| Dorland Y, Malinova T, van Stalborch A, Grieve A, van Geemen D, Jansen N, et al. The F-BAR protein pacsin2 inhibits asymmetric VE-cadherin internalization from tensile adherens junctions. Nat Commun. 2016;7:12210 pubmed publisher |
| Duvall Noelle N, Karwandyar A, Richmond A, Raman D. LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex. Oncogene. 2016;35:1122-33 pubmed publisher |
- immunocytochemistry; human; 1:50; fig 2c
- western blot; human; 1:1000; fig 2a
| MartÃnez Revollar G, Garay E, Martín Tapia D, Nava P, Huerta M, Lopez Bayghen E, et al. Heterogeneity between triple negative breast cancer cells due to differential activation of Wnt and PI3K/AKT pathways. Exp Cell Res. 2015;339:67-80 pubmed publisher |
- western blot; human; 1:2000
| Kourtidis A, Yanagisawa M, Huveldt D, Copland J, Anastasiadis P. Pro-Tumorigenic Phosphorylation of p120 Catenin in Renal and Breast Cancer. PLoS ONE. 2015;10:e0129964 pubmed publisher |
- immunohistochemistry - paraffin section; human; 1:1000
| Figueira A, Gomes C, Vilhena H, Miranda S, Carvalheira J, de Matos A, et al. Characterization of α-, β- and p120-Catenin Expression in Feline Mammary Tissues and their Relation with E- and P-Cadherin. Anticancer Res. 2015;35:3361-9 pubmed |
- immunohistochemistry - paraffin section; human
- western blot; human; 1:4000
| Mortazavi F, Lu J, Phan R, Lewis M, Trinidad K, Aljilani A, et al. Significance of KRAS/PAK1/Crk pathway in non-small cell lung cancer oncogenesis. BMC Cancer. 2015;15:381 pubmed publisher |
- immunohistochemistry; human; fig 3
| Bazellières E, Conte V, Elosegui Artola A, Serra Picamal X, Bintanel Morcillo M, Roca Cusachs P, et al. Control of cell-cell forces and collective cell dynamics by the intercellular adhesome. Nat Cell Biol. 2015;17:409-20 pubmed publisher |
- western blot; human; 1:2000
| Olsen P, Solberg N, Lund K, Vehus T, Gelazauskaite M, Wilson S, et al. Implications of targeted genomic disruption of β-catenin in BxPC-3 pancreatic adenocarcinoma cells. PLoS ONE. 2014;9:e115496 pubmed publisher |
| Short S, Kondo J, Smalley Freed W, Takeda H, Dohn M, Powell A, et al. p120-Catenin is an obligate haploinsufficient tumor suppressor in intestinal neoplasia. J Clin Invest. 2017;127:4462-4476 pubmed publisher |
| Mizoguchi T, Ikeda S, Watanabe S, Sugawara M, Itoh M. Mib1 contributes to persistent directional cell migration by regulating the Ctnnd1-Rac1 pathway. Proc Natl Acad Sci U S A. 2017;114:E9280-E9289 pubmed publisher |
| Labernadie A, Kato T, Brugués A, Serra Picamal X, Derzsi S, Arwert E, et al. A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion. Nat Cell Biol. 2017;19:224-237 pubmed publisher |
| Sakaue T, Fujisaki A, Nakayama H, Maekawa M, Hiyoshi H, Kubota E, et al. Neddylated Cullin 3 is required for vascular endothelial-cadherin-mediated endothelial barrier function. Cancer Sci. 2017;108:208-215 pubmed publisher |
| van de Ven R, de Groot J, Park D, van Domselaar R, de Jong D, Szuhai K, et al. p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis. Nat Commun. 2016;7:13874 pubmed publisher |
| Furukawa M, Wheeler S, Clark A, Wells A. Lung epithelial cells induce both phenotype alteration and senescence in breast cancer cells. PLoS ONE. 2015;10:e0118060 pubmed publisher |
| Rettig M, Trinidad K, Pezeshkpour G, Frost P, Sharma S, Moatamed F, et al. PAK1 kinase promotes cell motility and invasiveness through CRK-II serine phosphorylation in non-small cell lung cancer cells. PLoS ONE. 2012;7:e42012 pubmed publisher |
| Matise L, Palmer T, Ashby W, Nashabi A, Chytil A, Aakre M, et al. Lack of transforming growth factor-? signaling promotes collective cancer cell invasion through tumor-stromal crosstalk. Breast Cancer Res. 2012;14:R98 pubmed publisher |
| Lapierre L, Avant K, Caldwell C, Oztan A, Apodaca G, Knowles B, et al. Phosphorylation of Rab11-FIP2 regulates polarity in MDCK cells. Mol Biol Cell. 2012;23:2302-18 pubmed publisher |
| Géraud C, Evdokimov K, Straub B, Peitsch W, Demory A, Dörflinger Y, et al. Unique cell type-specific junctional complexes in vascular endothelium of human and rat liver sinusoids. PLoS ONE. 2012;7:e34206 pubmed publisher |
| Kivimäe S, Yang X, Cheyette B. All Dact (Dapper/Frodo) scaffold proteins dimerize and exhibit conserved interactions with Vangl, Dvl, and serine/threonine kinases. BMC Biochem. 2011;12:33 pubmed publisher |
| Smalley Freed W, Efimov A, Short S, Jia P, Zhao Z, Washington M, et al. Adenoma formation following limited ablation of p120-catenin in the mouse intestine. PLoS ONE. 2011;6:e19880 pubmed publisher |
| Mortazavi F, Dubinett S, Rettig M. c-Crk proto-oncogene contributes to transcriptional repression of p120-catenin in non-small cell lung cancer cells. Clin Exp Metastasis. 2011;28:391-404 pubmed publisher |
